Skip to main content
. 2018 Feb 15;15(4):5792–5798. doi: 10.3892/ol.2018.8059

Figure 1.

Figure 1.

TRIM29 expression in patients with gastric cancer with different TNM stages. The percentage of patients with low TRIM29 expression increased with disease progression from TNM stage I to III in the training and validation sets. TRIM29, tripartite motif containing 29; TNM, tumor-node-metastasis.